U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is questioning the safety and overuse of medications for anxiety treatment as nationwide prescription rates continue to rise. In contrast, mental health experts emphasize that properly prescribed medications for anxiety treatment remain safe and effective.
CDC Data Show Sharp Rise In Anxiety Medication Use
Federal data show a steady increase in the use of medications for anxiety treatment across the United States, particularly since the COVID‑19 pandemic.
According to the Centers for Disease Control and Prevention, the percentage of U.S. adults taking medication for anxiety rose from 11.7% in 2019 to 14.3% in 2024. That increase represents about 8 million more people, bringing the total to roughly 38 million adults.
Health officials say much of the growth occurred during the pandemic, when social isolation, economic uncertainty, and health fears intensified mental health challenges. The CDC reports particularly sharp increases among young adults, college-educated individuals, and adults who identify as LGBTQ+.
Anxiety disorders remain among the most common mental health conditions in the country. Public health researchers say symptoms of anxiety and depression have remained elevated even after pandemic restrictions eased.
Dr. Lisa Moreno, a psychiatrist at Georgetown University Hospital, said rising numbers reflect both increased need and greater willingness to seek care.
“Stigma around mental health treatment has declined in recent years,” Moreno said. “More patients are open to therapy and medication when symptoms interfere with daily life.”
Kennedy Raises Concerns About Overprescription
Kennedy has voiced concern about what he describes as the overprescription of psychiatric medications and potential long-term side effects.
In recent remarks, he questioned whether some patients are placed on medication too quickly without exploring alternative treatments. He also called for greater transparency in pharmaceutical research and regulation.
His comments come amid broader national debates over drug safety, clinical trial standards, and the role of pharmaceutical companies in shaping treatment guidelines.
Some Americans share concerns about dependency and adverse effects, particularly with certain short-term anti-anxiety drugs. However, many clinicians warn against broad conclusions.
Dr. Aaron Patel, a primary care physician in Chicago, said treatment decisions are individualized.
“Medication is not handed out casually,” Patel said. “We assess severity, medical history, and patient preference before prescribing. For many people, these medications are life-changing.”
Mental health advocates also caution that public skepticism could discourage patients from seeking needed care.
“Untreated anxiety can impair work, relationships, and physical health,” said Maria Torres, director of a national mental health nonprofit. “The conversation should focus on safe, evidence-based use, not fear.”
Experts Emphasize Evidence-Based, Combined Care
Psychiatrists explain that commonly prescribed medications for anxiety treatment—including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and, in limited cases, benzodiazepines—work by regulating brain chemicals linked to mood and stress response.
Side effects can include nausea, sleep disturbances, and temporary increases in anxiety during early treatment. Doctors say these effects are often mild and tend to diminish over time with monitoring.
Experts stress that medication is rarely the only approach. Cognitive behavioral therapy, stress management techniques, and lifestyle changes such as regular exercise and sleep hygiene are often recommended alongside medication.
“The gold standard is a combined approach,” Moreno said. “Therapy teaches coping skills, and medication can reduce symptom intensity so patients can fully engage in treatment.”
Physicians advise people experiencing persistent worry, panic attacks, sleep disruption, or difficulty concentrating to consult a licensed health care provider. Treatment plans should weigh risks, benefits, and patient preferences.
As anxiety treatment expands nationwide, officials acknowledge that the debate over psychiatric care is likely to continue. Health professionals stress that decisions involving medications for anxiety treatment should be guided by clinical evidence and tailored to individual needs.
“For patients, the message is simple,” Patel said. “Talk to your doctor. Make informed choices. Don’t let stigma prevent you from getting help.
Visit Healthcare 360 Magazine For The Most Recent Information.
